CIDP Neuropathy

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a neurological disorder characterized by gradual progressive weakness, pain and impaired sensory function in the legs and arms. Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common chronic autoimmune neuropathy.

CIDP can be frequently diagnosed as neuropathy “only” and no treatment is given to the patient. Whereas if the neuropathy is properly further diagnosed as CIDP sub-type, this can be treated and in some cases cured. 

Diagnosis is frequently delayed by several months or even years, resulting in significant nerve damage that may limit and delay the response to therapy.

Not all Neurologists are expert in diagnosing CIDP. Find out more about Neurologists who are expert in your area

The first-line treatment for CIDP nowadays is intravenous immunoglobulin (IVIG) and other treatments include steroids (prednisone), plasma exchange and immunosuppressant drugs.

The pattern of neuropathy is usually slow progressing symptoms of neuropathy and patient does not recieve treatment until they see an expert Neurologist

Read More